S. KILIÇKAP And Ç. ARSLAN, "Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients," JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , vol.301, no.14, pp.1435, 2009
KILIÇKAP, S. And ARSLAN, Ç. 2009. Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , vol.301, no.14 , 1435.
KILIÇKAP, S., & ARSLAN, Ç., (2009). Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , vol.301, no.14, 1435.
KILIÇKAP, SAADETTİN, And ÇAĞATAY ARSLAN. "Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients," JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , vol.301, no.14, 1435, 2009
KILIÇKAP, SAADETTİN And ARSLAN, ÇAĞATAY. "Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , vol.301, no.14, pp.1435, 2009
KILIÇKAP, S. And ARSLAN, Ç. (2009) . "Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , vol.301, no.14, p.1435.
@article{article, author={SAADETTİN KILIÇKAP And author={ÇAĞATAY ARSLAN}, title={Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients}, journal={JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION}, year=2009, pages={1435} }